Unveiling a key player in ovarian cancer survival

The initiative seeks to understand the crucial role of the omentum, a lesser-known yet vital organ in cancer treatment and overall health. From diagnosis to determination Meg’s journey with ovarian cancer began in 2014, marked by vague symptoms like nausea and abdominal distension. “I looked like I was four months pregnant by night,” she recalls.

Read More

Vox Pop Pharma – where will AI be in five years?

Industry leaders give their takes on what else is in store for AI-based tools in the pharma space. AI-powered algorithms have taken many industries by storm and pharma is no exception. For example, many companies are using AI to empower drug discovery​ and the search for disease targets by crunching reams of literature, helping human

Read More

CEO discusses hormone-free male birth control development

Bakshi shares the innovative approach of YCT-529, the results of their Phase 1a study, and the anticipated impact on reducing unintended pregnancies. This conversation highlights the significance of male contraception in the broader landscape of reproductive health and the challenges faced in pioneering such a transformative solution. What inspired you to develop a hormone-free birth

Read More

Unlocking innovation: Women in Science

 In this interview, she shares insights into her role, personal journey, challenges faced, and advice for aspiring women in science. Could you give us an overview of your work?​ ​ My role as a global technical developer at Roquette revolves around uncovering new ways to unlock business opportunities through high-quality pharmaceutical excipients. This can look like

Read More

Barriers to opioid treatment access in the US

This Q&A with Sheeba Ibidunni, public health expert and the VP of operations ​at Sonara Health explores the socio-economic factors fuelling the epidemic, the barriers to accessing life-saving medications, promising government interventions, the impact of state laws, and innovative solutions like telehealth platforms. Can you elaborate on the specific socio-economic factors that you believe are fueling

Read More

dsm-firmenich unveils advanced CBD drug product intermediate

The IP-protected CBD intermediate brings superior functionality allowing for a higher drug loading compared to currently commercially available products, paving the way for oral dosage forms with enhanced bioavailability. This will enable the development of more convenient and patient-friendly dosage forms – like tablets, including orally disintegrating tablets (ODTs) or chewables – making CBtru a

Read More

Eli Lilly enters $140M partnership with Radionetics Oncology

Eli Lilly has entered a strategic partnership with Radionetics Oncology, a biotechnology company focusing on the discovery and development of targeted radiopharmaceuticals to treat a broad range of solid tumors. As part of the agreement, Eli Lilly will pay $140 million upfront to Radionetics Oncology with the goal of advancing the company’s pipeline of drug

Read More

CatSci acquires Reach Separations to offer chromatography services

The deal was supported by Keensight Capital, a private equity manager focusing on pan-European investments in the technology and healthcare sectors. Headquartered in the UK, and with facilities in the UK and France, Reach Separations provides state-of-the-art chromatography services for the analysis and purification of therapeutics. The company makes use of supercritical fluid chromatography (SLC)

Read More